Ms. Koepp is a Protocol Coordinator at the DCC and has over 26 years of experience in clinical trials, including drug and device trials, in industry, contract research organizations, and academia. At the DCC, Ms. Koepp was the primary coordinator for the NN102 SPRINT-MS study, and is currently the primary coordinator for the NN108 TopCSPN study. As the Protocol Coordinator, she participates in protocol design and the development of data collection tools, monitors protocol compliance, and assures data completeness and accuracy. Ms. Koepp is also a member of the NeuroNEXT Education Committee.